Concepedia

Sagarika Bollini

SB

Statistics

Publications

7

Citations

332

H-Index

7

Active since

2000

Affiliations

Bristol-Myers Squibb (United States)(Current)

Sagarika Bollini is an author at Bristol-Myers Squibb (United States) specializing in drug discovery, pharmacy, and ligand binding.

Publications per year

2000–2022

7

Publications

7

2-Aryl-2,2-difluoroacetamide FKBP12 Ligands:  Synthesis and X-ray Structural Studies

Gene M. Dubowchik, Vivekananda M. Vrudhula, Bireshwar Dasgupta et al. · Organic Letters · 2001 · 104 citations

, , +11

High-Throughput Fluorescence Polarization Method for Identification of FKBP12 Ligands

Sagarika Bollini, John J. Herbst, G.T. Gaughan et al. · SLAS DISCOVERY · 2002 · 49 citations · Full text

, , +15

Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitors

B. Narasimhulu Naidu, Margaret E. Sorenson, Manoj Patel et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 48 citations · Full text

, , +14

Fluoresceinated FKBP12 ligands for a high-throughput fluorescence polarization assay

Gene M. Dubowchik, Jonathan L. Ditta, John J. Herbst et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 43 citations · Full text

, , +12

Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial

Gary Herman, Meagan P. O’Brien, Eduardo Forleo‐Neto et al. · The Lancet Infectious Diseases · 2022 · 41 citations · Full text

, , +8

1–5 of 7